Medicinal product name Besponsa
Pharmaceutical form Powder for concentrate for solution for infusion
Strength 1 mg 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.II stac.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Conclusion on the therapeutic and cost effectiveness of medicines Jul 5, 2023 C91.0
ATC code L01FB01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(1 mg)
Glass vial 12960.01  EU/1/17/1200/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/17/1200/001
Date of authorisation Jun 29, 2017
Marketing authorisation holder, country Pfizer Europe MA EEIG, Belgium